Table 1 Characteristics and clinical information of SLE patients

Age (years)

-

Disease duration (years)

-

Disease activity (SLEDAI) (n)

Active

Inactive

5.2 ± 1.26

1.4 ± 0.51

-

-

Complications (n)

Diabetes

Hypertension

Cardiac diseases

3

12

6

11

43

21

Medications (n)

Methotrexate

Cellecept

Prednisone

18

9

15

64

32

54

Immunological signs

Presence of anti-nuclear Ab (ANA) (titer > 1:40 was considered positive)

Abnormal anti-dsDNA Ab level (0-200 IU/ml)

Low complement levels (C3) (0.75–1.65 g/L)

Low complement levels (C4) (0.2–0.6 g/L)

20

501.7 ± 302

0.973 ± 0.19

0.2 ± 0.09

71

-

-

-

Complete blood count (CBC)

White blood cell (WBC) (4.5–11.5 K/UL)

Red blood cell (RBC) (4-5.4 M/µL)

Hemoglobin (HB) (12–15 g/dL)

Mean corpuscular volume (MCV) (80–94 fL)

Mean corpuscular hemoglobin (MCH) (32–36 pg)

Platelet (PLT) (150–450 K/UL)

5.96 ± 1.9

4.44 ± 0.79

12.42 ± 5.31

79.05 ± 10.09

25.96 ± 4.11

260.17 ± 73.31

-

Kidney and liver function tests

Urea (3.2–8.2 mmol/L)

Creatinine (53–115 µmol/L)

Alanine aminotransferase (ALT) (12–78 U/L)

Aspartate aminotransferase (AST) (15–37 U/L)

7.23 ± 5.25

83.11 ± 44.33

22 ± 9.61

18.34 ± 5.54

-